Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 10/20 | 0.48 |
| ▸ | CASP2 | P42575 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1285950 | 0.98 | EPHX1 (0.50) | EPHX1CASP2IDO1ZDHHC20ZDHHC2 | |
| SCHEMBL1285963 | 0.96 | EPHX1 (0.46) | EPHX1CASP2IDO1ZDHHC20ZDHHC2 | |
| SCHEMBL1286292 | 0.89 | — | — | |
| SCHEMBL27914218 | 0.83 | EPHX1 (0.48) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL28757302 | 0.83 | EPHX1 (0.48) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL27671249 | 0.83 | EPHX1 (0.48) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL27775479 | 0.83 | EPHX1 (0.48) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL27428077 | 0.83 | EPHX1 (0.48) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL27823591 | 0.83 | EPHX1 (0.48) | EPHX1CASP2ZDHHC20ZDHHC2NAAA | |
| SCHEMBL28240095 | 0.83 | EPHX1 (0.48) | EPHX1CASP2ZDHHC20ZDHHC2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060142621-A1 | Bismuth dithiocarbamate compounds and uses thereof | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142621-A1 | Bismuth dithiocarbamate compounds and uses thereof | RB1, PBRM1, REL | EPHX1 3581/4885CASP2 3740/4885IDO1 2357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.